New research on #mpox in South Kivu, Democratic Republic of the Congo, analysed 652 adults hospitalised between 2024-2025. Key findings: 🔹 84.6% of patients with available severity data had moderate or severe mpox. 🔹 Overall in-hospital mortality was 2.2%. 🔹 HIV infection was identified in 7% of those tested and appeared to be associated with greater disease severity and mortality. 🔹 Increasing age was associated with longer hospitalisation. Supported by Global Health EDCTP3-funded PREGMPOX project. 🔗 Read the article: https://lnkd.in/eeTZzaRn 📷 Location of the five participating mpox treatment centres in South Kivu Province, Democratic Republic of the Congo. #GlobalHealthEDCTP3Knowledge
Global Health EDCTP3
Research Services
The African and European research partnership on infectious diseases
About us
We fund clinical trials and studies, train researchers, and strengthen the African clinical research ecosystem, ensuring that solutions are developed where they are most needed and global health security is increased. Global Health EDCTP3 is a unique European and African partnership working to improve health through research. Backed by the European Union and over 40 countries, we focus on infectious diseases that continue to harm millions across sub-Saharan Africa.
- Website
-
https://www.global-health-edctp3.europa.eu/
External link for Global Health EDCTP3
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Brussels
- Type
- Partnership
- Founded
- 2021
Locations
-
Primary
Get directions
Avenue de la Toison d'Or 56-60
Brussels, BE
Employees at Global Health EDCTP3
Updates
-
A new AI-powered diagnostic approach could help identify more people with #tuberculosis. 💡 The newly launched AddiCAD project will combine AI-powered chest X-ray analysis with a simple fingerstick blood test to improve TB detection. Building on promising early findings, the approach achieved a 20% improvement in specificity compared with AI imaging alone, while maintaining high sensitivity. 🤝 Funded by Global Health EDCTP3, the €2.5 million project brings together partners from Africa and Europe to develop and validate this innovative non-sputum-based diagnostic solution in around 1,000 adults across South Africa, Namibia and The Gambia. 🔗 Read more: https://lnkd.in/e-kkWVsp ▶️ Full video: https://lnkd.in/eGJtxGGp Stellenbosch University
-
Meet the six researchers selected for the first The SAHRI Fellowship Program cohort (2026-2029) 🌍 From Zambia, Uganda, Zimbabwe and Ethiopia, these emerging researchers will strengthen their expertise through a three-stage programme combining advanced academic training, an industry placement and applied research in their home countries. 🔹 Kwitaka Maluzi - Molecular biology 🔹 Judith Ayebare - Medicine & public health 🔹 Arthur Vengesai - Biomedical science 🔹 Linda R. Buluma - Medicine & clinical research 🔹 Bedemariam Amsalu - Medicine 🔹 Carolyn Nayebare - Biomedical engineering We are proud to support the SAHRI Fellowship Programme as it invests in the next generation of health research leaders across sub-Saharan Africa. 👉 Learn more about the programme: https://lnkd.in/e8yUz_vX Institute of Tropical Medicine Antwerp KCMC University Kenya Medical Research Institute (KEMRI) Access-To-Medicines Research Centre (ATM) Jimma University University of Rwanda Clinical Research Unit of Nanoro (CRUN / URCN) National Institute for Medical Research (NIMR) - Tanzania BioNTech SE
-
🩹 Safe care for life! On #WorldPatientSafetyDay, we highlight the importance of safe, quality care throughout a patient's journey, including for people living with both infectious diseases and non-communicable diseases (NCDs). 💡 As health conditions increasingly overlap, understanding how infectious diseases interact with #NCDs is essential to improving prevention, diagnosis and treatment, and delivering safer, more integrated care. At Global Health EDCTP3, we are strengthening our focus on this intersection, notably through our recent partnership with the Novo Nordisk Foundation. 🔗 Learn more about our partnership: https://lnkd.in/eVvqU-Zd World Health Organization
-
Congratulations to Professor Roma Chilengi on his appointment as #Zambia’s new Minister of Health. A clinical trials specialist with extensive experience in vaccine research, Professor Chilengi has contributed to work on malaria, rotavirus and HIV, as well as to the rollout of rotavirus vaccination in Zambia. We are particularly proud to have supported his work through an #EDCTP Senior Fellowship in 2017, investigating whether a third dose of rotavirus vaccine at nine months could strengthen immune responses and provide longer-lasting protection. His engagement with the European & Developing Countries Clinical Trials Partnership (EDCTP) has continued, including through the Steering Committee of a project evaluating a new Shigella vaccine. Professor Chilengi has also brought his scientific expertise directly into public health leadership, including as Special Advisor on COVID-19 to President Hakainde Hichilema. We wish Professor Chilengi every success in his new role and look forward to seeing his expertise and leadership continue to make a difference for public health in Zambia and beyond. Find out more: https://lnkd.in/eguwVg_9
-
-
Who will join us at the Science Summit 2026 held alongside #UNGA81? On 22 September, Global Health EDCTP3 will bring together African and international leaders to discuss how we can strengthen clinical research across Africa and beyond. 📅 22 September 2026 | 11:00-13:30 EDT 📍 New York + Online Meet our speakers: 🔹 Michael Makanga, Global Health EDCTP3 🔹 Lara Pandya, Global Health EDCTP3 🔹 Maria Pilar AGUAR FERNANDEZ, European Commission 🔹 Richard Hatchett, CEPI 🔹 Jennifer Dent, BIO Ventures for Global Health 🔹 Mark Feinberg, IAVI 🔹 Prof Alex Dodoo, African Medicines Agency 🔹 Ntobeko Ntusi, South African Medical Research Council 🔹 Achim Hoerauf, IMMIP 🔹 Rella Zoleko-Manego, CERMEL 🔹 Maria do Céu Patrão Neves, Portuguese National Council of Ethics 🔹 Esperança Sevene, Eduardo Mondlane University 🔹 Kanteh Dembo, The Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine 🔹 Dorothy Yeboah-Manu, University of Ghana 🔹 Katharina Kranzer, The Health Research Unit Zimbabwe 🔗 Register now: https://lnkd.in/dPGcTxf7 #ScienceSummit2026
-
-
-
-
-
+10
-
-
Applications are open for the 14th Clinic on Dynamical Approaches to Infectious Disease Data (#DAIDD). 📅 29 November-5 December 2026 📍 Nairobi, Kenya ⏰ Application deadline: 22 September 2026 This intensive one-week clinic will introduce participants to dynamical modelling for infectious disease research through interactive lectures, tutorials and hands-on work to develop a research plan integrating modelling with data collection and analysis. Postgraduate students and researchers with an interest in infectious disease research are encouraged to apply. 🤝 The clinic is organised by the #ICI3D project, funded by Global Health EDCTP3 and CEPI (Coalition for Epidemic Preparedness Innovations) through a co-funding partnership. 🔗 Apply now: https://lnkd.in/e_E3fbQH SACEMA (South African Centre for Epidemiological Modelling and Analysis) CERI - Centre for Epidemic Response and Innovation Center for Epidemiological Modelling and Analysis (CEMA-Africa)
-
-
💡 Free #webinar | 'Adaptive platforms for neonatal sepsis research: insights from SNIP-AFRICA and NeoSep-ADAPT' How can adaptive research platforms help generate better evidence and improve outcomes for newborns with sepsis? To mark #WorldSepsisDay, join a free Penta - Child Health Research webinar featuring insights from the Global Health EDCTP3-funded SNIP-AFRICA project and NeoSep-ADAPT. 📅 17 September 2026 🕐 13:30-15:00 CEST ℹ️ Info and agenda: https://lnkd.in/enjj2rY7 Hear directly from the researchers behind adaptive trials, clinical and microbiological surveillance, dose-optimisation studies and long-term follow-up research. Together, these approaches are helping build more connected and responsive research to improve outcomes for newborns in resource-limited settings. 🔗 Register: https://lnkd.in/gzGYcJ-D
-
-
What if mothers living with #HIV could #breastfeed without putting their babies at risk? The #EDCTP-funded Kesho Bora trial helped show that they could. 💡 Involving 824 pregnant women across Burkina Faso, Kenya and South Africa, the trial found that a three-drug antiretroviral regimen reduced HIV transmission to babies by 43% compared with the standard treatment at the time. The findings helped shape World Health Organization guidance and contributed to the adoption of Option B and Option B+, changing how HIV prevention during pregnancy and breastfeeding was approached across Africa. 🔗 Read the story: https://lnkd.in/gxBJRYWQ European & Developing Countries Clinical Trials Partnership (EDCTP)
-
-
‼️ Record submissions for the EDCTP Forum 2027: 1,130 abstracts, 72 scientific symposia and 44 workshops! 🤝 Thank you to everyone who submitted their research work and proposals. We look forward to reviewing your contributions and shaping an exciting scientific programme. 📅 5-9 April 2027 📍 Madrid, Spain Applicants will be informed of the results of the three calls by December 2026. Good luck to all! 🔗 Discover more: https://edctpforum.eu/
-